## Answer
(model generated chain of thought explanation)

Given the clinical presentation of a 26-year-old woman at 26 weeks’ gestation with pain and swelling in her right calf, increased circumference of the calf, warm and tender leg on palpation, and dorsiflexion-induced calf pain, along with an ultrasound showing a noncompressible popliteal vein, the most likely diagnosis is deep vein thrombosis (DVT).

The presence of DVT is confirmed by the physical examination findings and the ultrasound results. The fact that the patient is at 26 weeks’ gestation increases the risk for DVT due to the increased venous stasis caused by the pregnancy.

Pharmacotherapy for DVT typically involves anticoagulation therapy to prevent further clot formation and pulmonary embolism (PE). Given the options provided:

A. Aspirin - While aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that can help reduce inflammation, it is not an effective anticoagulant for DVT.

B. Clopidogrel - This is an antiplatelet medication used to prevent blood clots from forming in patients with coronary artery disease or those at high risk of cardiovascular events. It is not the first-line treatment for DVT.

C. Heparin - This is a direct thrombin inhibitor that is commonly used as an anticoagulant for the prevention and treatment of DVT. Given its effectiveness, heparin is often considered the first-line treatment for DVT in pregnant women due to its safety profile during pregnancy.

D. Warfarin - Although warfarin is an effective anticoagulant, it is not typically used as a first-line treatment for DVT in pregnant women due to its potential risks and side effects, particularly in the third trimester.

Therefore, considering the clinical presentation and ultrasound findings suggestive of DVT, the most appropriate pharmacotherapy for this patient's condition would be heparin.